Our price guide goes back nearly 20 years. We’ve added a lot of vehicles in that time, but it essentially works the same as ...

Novartis and Gilead’s CAR-T therapies have been approved in Europe – and the UK’s NICE immediately slapped down the latter, saying it is too expensive for regular NHS use in England and Wales.